Biomarker Research的2023年影响因子为11.1,这一数值表明该期刊在生物标志物研究领域具有较高的学术影响力。以下从多个
Biomarker Researchoffers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published...
Biomarker Research encompasses every aspect of biomarker investigation from all biomedical disciplines. The journal recognizes that the study of biomarkers ...
Biomarker Research is an open access, peer-reviewed journal that encompasses all aspects of biomarker investigation. Biomarker Research aims to publish original discoveries, novel concepts, commentaries and reviews related to biomarker investigation from all biomedical disciplines. The study of biomarkers has...
学科:MEDICINE, RESEARCH & EXPERIMENTALSCIEQ120 / 189 89.68% 学科:ONCOLOGYSCIEQ140 / 322 87.73% 名词解释: 汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中...
These have the potential to impact significantly on the constituents of the resulting processed sample matrix, thereby complicating the elucidation of the functional role of EVs, biomarker discovery efforts and targeted analytical assay development. Despite worldwide interest in this research area, only ...
The identified proteins may serve as diagnostic biomarkers or therapeutic targets for radon-related lung cancer.doi:10.1093/jrr/rraf010Subsomwong PhawineeKranrod ChutimaSakai YunaAsano KrisanaNakane AkioTokonami ShinjiJournal of Radiation Research
The importance of mild and moderate TBI Research in the field of TBI has long been dominated by research on severe brain injury. However, of the estimated 1.8 million people in the United States who sustain a TBI each year, over 90% will have either a "moderate" (GCS 9-12) or "mild...
and high KIF2A expression was subsequently determined to be an independent hazard factor for poor survival outcomes via the univariate and multivariate cox analyses. Meanwhile, by combining with corresponding clinicopathological features of HCC patients, the research further noted that KIF2A expression wa...
Chimeric antigen receptor (CAR) T cell therapy, in which a patient’s own T lymphocytes are engineered to recognize and kill cancer cells, has achieved striking success in some hematological malignancies in preclinical and clinical trials, resulting in s